Corteva Earnings Calls
| Release date | Jul 30, 2026 |
| EPS estimate | 1.92€ |
| EPS actual | - |
| Revenue estimate | 5.667B |
| Revenue actual | - |
| Expected change | +/- 0.460% |
| Release date | May 05, 2026 |
| EPS estimate | 1.02€ |
| EPS actual | 1.30€ |
| EPS Surprise | 27.45% |
| Revenue estimate | 4.015B |
| Revenue actual | 4.245B |
| Revenue Surprise | 5.73% |
| Release date | Feb 03, 2026 |
| EPS estimate | 0.190€ |
| EPS actual | 0.187€ |
| EPS Surprise | -1.32% |
| Revenue estimate | 3.61B |
| Revenue actual | 3.329B |
| Revenue Surprise | -7.78% |
| Release date | Nov 04, 2025 |
| EPS estimate | -0.432€ |
| EPS actual | -0.403€ |
| EPS Surprise | 6.77% |
| Revenue estimate | 2.468B |
| Revenue actual | 2.235B |
| Revenue Surprise | -9.42% |
Last 4 Quarters for Corteva
Below you can see how 2X0.DE performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Nov 04, 2025 |
| Price on release | 54.42€ |
| EPS estimate | -0.432€ |
| EPS actual | -0.403€ |
| EPS surprise | 6.77% |
| Date | Price |
|---|---|
| Oct 29, 2025 | 54.22€ |
| Oct 30, 2025 | 53.52€ |
| Oct 31, 2025 | 53.23€ |
| Nov 03, 2025 | 53.25€ |
| Nov 04, 2025 | 54.42€ |
| Nov 05, 2025 | 54.42€ |
| Nov 06, 2025 | 54.73€ |
| Nov 07, 2025 | 54.90€ |
| Nov 10, 2025 | 54.90€ |
| 4 days before | 0.369% |
| 4 days after | 0.88% |
| On release day | 0% |
| Change in period | 1.25% |
| Release date | Feb 03, 2026 |
| Price on release | 63.48€ |
| EPS estimate | 0.190€ |
| EPS actual | 0.187€ |
| EPS surprise | -1.32% |
| Date | Price |
|---|---|
| Jan 28, 2026 | 61.37€ |
| Jan 29, 2026 | 61.60€ |
| Jan 30, 2026 | 61.52€ |
| Feb 02, 2026 | 62.10€ |
| Feb 03, 2026 | 63.48€ |
| Feb 04, 2026 | 63.98€ |
| Feb 05, 2026 | 61.65€ |
| Feb 06, 2026 | 61.41€ |
| Feb 09, 2026 | 62.02€ |
| 4 days before | 3.44% |
| 4 days after | -2.30% |
| On release day | 0.788% |
| Change in period | 1.06% |
| Release date | May 05, 2026 |
| Price on release | 67.68€ |
| EPS estimate | 1.02€ |
| EPS actual | 1.30€ |
| EPS surprise | 27.45% |
| Date | Price |
|---|---|
| Apr 28, 2026 | 67.68€ |
| Apr 29, 2026 | 67.68€ |
| Apr 30, 2026 | 67.68€ |
| May 04, 2026 | 67.68€ |
| May 05, 2026 | 67.68€ |
| May 06, 2026 | 67.68€ |
| May 07, 2026 | 67.68€ |
| May 08, 2026 | 67.68€ |
| May 11, 2026 | 67.68€ |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
| Release date | Jul 30, 2026 |
| Price on release | - |
| EPS estimate | 1.92€ |
| EPS actual | - |
| Date | Price |
|---|---|
| Jun 29, 2026 | 67.68€ |
| Jun 30, 2026 | 67.68€ |
| Jul 01, 2026 | 67.68€ |
| Jul 02, 2026 | 67.68€ |
| Jul 03, 2026 | 67.68€ |
Corteva Earnings Call Transcript Summary of Q1 2026
Corteva reported a strong start to 2026 with Q1 organic sales up 7% (seed +9%, crop protection +4%) and operating EBITDA up 21% YoY, driven by price/mix, volume, productivity and favorable currency. Both Seed and Crop Protection delivered double-digit EBITDA gains; seed benefited from North American timing shifts and continued pricing-for-value, while crop protection saw broad-based volume strength, notably in new products and Spinosyns. Management reaffirmed full-year guidance (operating EBITDA $4.0–4.2B; operating EPS $3.45–3.70) and expects mid-single-digit volume growth for Corteva overall with continued margin expansion from controllable levers. Key operational updates: royalty trajectory improving (crossing into royalty-positive later this year), separation progress on track for a Q4 2026 split (initial Form 10 filed; new seed company named Vylor; estimated one-time separation costs ~$350M; net dis-synergies trending favorably with $50M included in 2026 guide), a $1.5B discretionary pension contribution approved to support standalone capital structures, and continued capital return (~$500M share repurchases planned in H1). Risks flagged: higher oil prices (sized as a ~$40M headwind), tariffs (slightly better than previously expected), geopolitical uncertainty (monitoring Middle East impacts on oil and feedstocks), and typical seasonal timing/acreage risks in H2 (notably potential shifts between corn and soy acres). Management highlighted growth opportunities from licensing (corn/soy traits), hybrid wheat, gene editing, biologicals and new crop protection actives, and reiterated an Investor Day on September 15, 2026 for multi-year plans.
Sign In
Buy 2X0